Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells
- 3 December 2008
- Vol. 27 (5) , 684-689
- https://doi.org/10.1016/j.vaccine.2008.11.042
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma PatientsClinical Cancer Research, 2008
- Mechanisms of Immune Evasion by TumorsPublished by Elsevier ,2006
- In Vivo Depletion of CD4+CD25+ Regulatory T Cells Enhances the Antigen-Specific Primary and Memory CTL Response Elicited by Mature mRNA-Electroporated Dendritic CellsMolecular Therapy, 2005
- Immunosuppressive networks in the tumour environment and their therapeutic relevanceNature Reviews Cancer, 2005
- Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumorsThe Journal of Experimental Medicine, 2005
- Dominant tolerance: activation thresholds for peripheral generation of regulatory T cellsTrends in Immunology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Depletion of CD25+CD4+T cells (Tregs) enhances the HBV-specific CD8+T cell response primed by DNA immunizationWorld Journal of Gastroenterology, 2005
- CD4+CD25+T Cells Regulate Vaccine-Generated Primary and Memory CD8+T-Cell Responses against Herpes Simplex Virus Type 1Journal of Virology, 2004
- Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen NonspecificThe Journal of Immunology, 2000